Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$20,290,932
+$768,976 QoQ
Shares Held
79,895
+0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#736
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. JNJ ranks #2 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,290,932 | 79,895 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $19,521,956 | 79,864 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,748,049 | 80,928 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $15,188,307 | 81,913 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,637,771 | 82,735 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,882,361 | 107,829 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $15,730,172 | 108,769 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $17,661,298 | 108,980 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $16,011,389 | 109,547 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $17,593,100 | 111,215 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $17,532,935 | 111,860 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $17,490,569 | 112,299 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $18,631,924 | 112,566 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $25,536,870 | 164,754 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $28,522,438 | 161,463 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $26,452,231 | 161,926 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $28,736,738 | 161,888 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $29,172,412 | 164,602 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $57,527,419 | 336,280 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $54,864,618 | 339,719 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $55,860,368 | 339,082 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $55,440,513 | 337,332 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $52,874,485 | 335,967 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $48,163,275 | 323,504 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $45,497,883 | 323,529 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $43,314,074 | 330,314 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||